KR20240019264A - 매독 트레포네마 균의 표면 항원의 혼합물을 사용하는, 항 매독 트레포네마 체액 항체의 측정 - Google Patents
매독 트레포네마 균의 표면 항원의 혼합물을 사용하는, 항 매독 트레포네마 체액 항체의 측정 Download PDFInfo
- Publication number
- KR20240019264A KR20240019264A KR1020247000546A KR20247000546A KR20240019264A KR 20240019264 A KR20240019264 A KR 20240019264A KR 1020247000546 A KR1020247000546 A KR 1020247000546A KR 20247000546 A KR20247000546 A KR 20247000546A KR 20240019264 A KR20240019264 A KR 20240019264A
- Authority
- KR
- South Korea
- Prior art keywords
- antigen
- gene
- syphilis
- recombinant
- body fluid
- Prior art date
Links
- 108091007433 antigens Proteins 0.000 title claims abstract description 178
- 102000036639 antigens Human genes 0.000 title claims abstract description 159
- 239000000427 antigen Substances 0.000 title claims abstract description 158
- 239000000203 mixture Substances 0.000 title claims abstract description 67
- 208000006379 syphilis Diseases 0.000 title claims abstract description 48
- 238000005259 measurement Methods 0.000 title claims abstract description 15
- 241000894006 Bacteria Species 0.000 title 1
- 210000001124 body fluid Anatomy 0.000 claims abstract description 70
- 239000010839 body fluid Substances 0.000 claims abstract description 68
- 241000255789 Bombyx mori Species 0.000 claims abstract description 53
- 238000000691 measurement method Methods 0.000 claims abstract description 30
- 230000004927 fusion Effects 0.000 claims abstract description 20
- 241000589886 Treponema Species 0.000 claims abstract description 12
- 210000004907 gland Anatomy 0.000 claims abstract description 11
- 230000001900 immune effect Effects 0.000 claims abstract description 10
- 238000000034 method Methods 0.000 claims description 60
- 108090000623 proteins and genes Proteins 0.000 claims description 58
- 239000002245 particle Substances 0.000 claims description 39
- 239000004816 latex Substances 0.000 claims description 30
- 229920000126 latex Polymers 0.000 claims description 30
- 239000012071 phase Substances 0.000 claims description 24
- 239000007790 solid phase Substances 0.000 claims description 21
- 230000004520 agglutination Effects 0.000 claims description 19
- 108090000790 Enzymes Proteins 0.000 claims description 16
- 102000004190 Enzymes Human genes 0.000 claims description 16
- 238000003018 immunoassay Methods 0.000 claims description 16
- 230000009471 action Effects 0.000 claims description 12
- 210000004369 blood Anatomy 0.000 claims description 9
- 239000008280 blood Substances 0.000 claims description 9
- 238000003317 immunochromatography Methods 0.000 claims description 9
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 7
- 238000003127 radioimmunoassay Methods 0.000 claims description 7
- 210000000601 blood cell Anatomy 0.000 claims description 5
- 238000007711 solidification Methods 0.000 claims description 5
- 230000008023 solidification Effects 0.000 claims description 5
- 201000010099 disease Diseases 0.000 claims description 4
- 230000001404 mediated effect Effects 0.000 claims description 4
- 239000008346 aqueous phase Substances 0.000 claims 1
- 208000015181 infectious disease Diseases 0.000 abstract description 13
- 230000035945 sensitivity Effects 0.000 abstract description 9
- 238000006243 chemical reaction Methods 0.000 description 49
- 238000011161 development Methods 0.000 description 21
- 239000012634 fragment Substances 0.000 description 16
- 238000012360 testing method Methods 0.000 description 16
- 239000003153 chemical reaction reagent Substances 0.000 description 15
- 108020004414 DNA Proteins 0.000 description 14
- 230000014509 gene expression Effects 0.000 description 14
- 238000002965 ELISA Methods 0.000 description 13
- 239000000047 product Substances 0.000 description 13
- 239000000243 solution Substances 0.000 description 13
- 102100039556 Galectin-4 Human genes 0.000 description 11
- 101000608765 Homo sapiens Galectin-4 Proteins 0.000 description 11
- 108010013296 Sericins Proteins 0.000 description 11
- 239000012528 membrane Substances 0.000 description 10
- 210000002966 serum Anatomy 0.000 description 10
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 9
- 241000588724 Escherichia coli Species 0.000 description 8
- 238000010367 cloning Methods 0.000 description 8
- 239000008363 phosphate buffer Substances 0.000 description 7
- 229940039354 sericin 1 Drugs 0.000 description 7
- 239000013598 vector Substances 0.000 description 7
- 101100046775 Arabidopsis thaliana TPPA gene Proteins 0.000 description 6
- 230000004544 DNA amplification Effects 0.000 description 6
- 238000010586 diagram Methods 0.000 description 6
- XZZNDPSIHUTMOC-UHFFFAOYSA-N triphenyl phosphate Chemical compound C=1C=CC=CC=1OP(OC=1C=CC=CC=1)(=O)OC1=CC=CC=C1 XZZNDPSIHUTMOC-UHFFFAOYSA-N 0.000 description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
- 230000002776 aggregation Effects 0.000 description 5
- 238000004220 aggregation Methods 0.000 description 5
- 230000003321 amplification Effects 0.000 description 5
- 239000011324 bead Substances 0.000 description 5
- 239000000084 colloidal system Substances 0.000 description 5
- 239000000463 material Substances 0.000 description 5
- 238000003199 nucleic acid amplification method Methods 0.000 description 5
- 230000001235 sensitizing effect Effects 0.000 description 5
- 206010070834 Sensitisation Diseases 0.000 description 4
- 241000589884 Treponema pallidum Species 0.000 description 4
- 238000003745 diagnosis Methods 0.000 description 4
- 238000010790 dilution Methods 0.000 description 4
- 239000012895 dilution Substances 0.000 description 4
- 239000003623 enhancer Substances 0.000 description 4
- 238000002372 labelling Methods 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- 239000003550 marker Substances 0.000 description 4
- 239000011859 microparticle Substances 0.000 description 4
- 230000008313 sensitization Effects 0.000 description 4
- 239000000758 substrate Substances 0.000 description 4
- 238000012800 visualization Methods 0.000 description 4
- 238000005406 washing Methods 0.000 description 4
- 241000725101 Clea Species 0.000 description 3
- 101150077230 GAL4 gene Proteins 0.000 description 3
- 241000238631 Hexapoda Species 0.000 description 3
- 241001071864 Lethrinus laticaudis Species 0.000 description 3
- 238000010521 absorption reaction Methods 0.000 description 3
- 239000003125 aqueous solvent Substances 0.000 description 3
- 238000004040 coloring Methods 0.000 description 3
- 239000002131 composite material Substances 0.000 description 3
- 239000012636 effector Substances 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 108091006047 fluorescent proteins Proteins 0.000 description 3
- 239000003365 glass fiber Substances 0.000 description 3
- 239000007791 liquid phase Substances 0.000 description 3
- 239000002184 metal Substances 0.000 description 3
- 229910052751 metal Inorganic materials 0.000 description 3
- 239000013600 plasmid vector Substances 0.000 description 3
- 102000004169 proteins and genes Human genes 0.000 description 3
- 238000000746 purification Methods 0.000 description 3
- 230000006798 recombination Effects 0.000 description 3
- 208000024891 symptom Diseases 0.000 description 3
- 230000009261 transgenic effect Effects 0.000 description 3
- 238000002834 transmittance Methods 0.000 description 3
- 238000011144 upstream manufacturing Methods 0.000 description 3
- 102000002260 Alkaline Phosphatase Human genes 0.000 description 2
- 108020004774 Alkaline Phosphatase Proteins 0.000 description 2
- 208000034048 Asymptomatic disease Diseases 0.000 description 2
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 2
- 108091033409 CRISPR Proteins 0.000 description 2
- 229920000742 Cotton Polymers 0.000 description 2
- 108010010803 Gelatin Proteins 0.000 description 2
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 2
- 239000000020 Nitrocellulose Substances 0.000 description 2
- 108091028043 Nucleic acid sequence Proteins 0.000 description 2
- 241000283977 Oryctolagus Species 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- 239000004098 Tetracycline Substances 0.000 description 2
- 102000008579 Transposases Human genes 0.000 description 2
- 108010020764 Transposases Proteins 0.000 description 2
- 235000010724 Wisteria floribunda Nutrition 0.000 description 2
- 238000002835 absorbance Methods 0.000 description 2
- 239000012190 activator Substances 0.000 description 2
- 239000003242 anti bacterial agent Substances 0.000 description 2
- 229940088710 antibiotic agent Drugs 0.000 description 2
- 229940098773 bovine serum albumin Drugs 0.000 description 2
- 239000007853 buffer solution Substances 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 210000000349 chromosome Anatomy 0.000 description 2
- 239000011248 coating agent Substances 0.000 description 2
- 238000000576 coating method Methods 0.000 description 2
- 230000002860 competitive effect Effects 0.000 description 2
- 230000000295 complement effect Effects 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 210000003743 erythrocyte Anatomy 0.000 description 2
- 239000000284 extract Substances 0.000 description 2
- 102000034287 fluorescent proteins Human genes 0.000 description 2
- 239000008273 gelatin Substances 0.000 description 2
- 229920000159 gelatin Polymers 0.000 description 2
- 235000019322 gelatine Nutrition 0.000 description 2
- 235000011852 gelatine desserts Nutrition 0.000 description 2
- 230000002068 genetic effect Effects 0.000 description 2
- 230000035931 haemagglutination Effects 0.000 description 2
- 230000036039 immunity Effects 0.000 description 2
- 229920001220 nitrocellulos Polymers 0.000 description 2
- 102000013415 peroxidase activity proteins Human genes 0.000 description 2
- 108040007629 peroxidase activity proteins Proteins 0.000 description 2
- 239000002504 physiological saline solution Substances 0.000 description 2
- 238000012123 point-of-care testing Methods 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 238000005215 recombination Methods 0.000 description 2
- 230000003252 repetitive effect Effects 0.000 description 2
- 108091008146 restriction endonucleases Proteins 0.000 description 2
- 238000012552 review Methods 0.000 description 2
- 239000012086 standard solution Substances 0.000 description 2
- 239000011550 stock solution Substances 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- 210000001550 testis Anatomy 0.000 description 2
- 229960002180 tetracycline Drugs 0.000 description 2
- 229930101283 tetracycline Natural products 0.000 description 2
- 235000019364 tetracycline Nutrition 0.000 description 2
- 150000003522 tetracyclines Chemical class 0.000 description 2
- 238000011426 transformation method Methods 0.000 description 2
- GPRLSGONYQIRFK-MNYXATJNSA-N triton Chemical compound [3H+] GPRLSGONYQIRFK-MNYXATJNSA-N 0.000 description 2
- SGKRLCUYIXIAHR-AKNGSSGZSA-N (4s,4ar,5s,5ar,6r,12ar)-4-(dimethylamino)-1,5,10,11,12a-pentahydroxy-6-methyl-3,12-dioxo-4a,5,5a,6-tetrahydro-4h-tetracene-2-carboxamide Chemical compound C1=CC=C2[C@H](C)[C@@H]([C@H](O)[C@@H]3[C@](C(O)=C(C(N)=O)C(=O)[C@H]3N(C)C)(O)C3=O)C3=C(O)C2=C1O SGKRLCUYIXIAHR-AKNGSSGZSA-N 0.000 description 1
- KPZGRMZPZLOPBS-UHFFFAOYSA-N 1,3-dichloro-2,2-bis(chloromethyl)propane Chemical compound ClCC(CCl)(CCl)CCl KPZGRMZPZLOPBS-UHFFFAOYSA-N 0.000 description 1
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 1
- UAIUNKRWKOVEES-UHFFFAOYSA-N 3,3',5,5'-tetramethylbenzidine Chemical compound CC1=C(N)C(C)=CC(C=2C=C(C)C(N)=C(C)C=2)=C1 UAIUNKRWKOVEES-UHFFFAOYSA-N 0.000 description 1
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 description 1
- 241000255794 Bombyx mandarina Species 0.000 description 1
- 238000010354 CRISPR gene editing Methods 0.000 description 1
- 108091026890 Coding region Proteins 0.000 description 1
- 108020004705 Codon Proteins 0.000 description 1
- 208000003322 Coinfection Diseases 0.000 description 1
- 108010043121 Green Fluorescent Proteins Proteins 0.000 description 1
- 241001646125 Mandarina Species 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- 208000037581 Persistent Infection Diseases 0.000 description 1
- 108091027981 Response element Proteins 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 1
- 239000012506 Sephacryl® Substances 0.000 description 1
- 208000019802 Sexually transmitted disease Diseases 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 1
- 241000589970 Spirochaetales Species 0.000 description 1
- 238000010459 TALEN Methods 0.000 description 1
- 101150009841 TP gene Proteins 0.000 description 1
- 108010043645 Transcription Activator-Like Effector Nucleases Proteins 0.000 description 1
- 108091023040 Transcription factor Proteins 0.000 description 1
- 102000040945 Transcription factor Human genes 0.000 description 1
- 108700019146 Transgenes Proteins 0.000 description 1
- 239000002250 absorbent Substances 0.000 description 1
- 230000002745 absorbent Effects 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 125000003275 alpha amino acid group Chemical group 0.000 description 1
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 1
- 229910052921 ammonium sulfate Inorganic materials 0.000 description 1
- 235000011130 ammonium sulphate Nutrition 0.000 description 1
- 239000003146 anticoagulant agent Substances 0.000 description 1
- 229940127219 anticoagulant drug Drugs 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 238000011088 calibration curve Methods 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000012767 chemiluminescent enzyme immunoassay Methods 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 239000003593 chromogenic compound Substances 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 238000009402 cross-breeding Methods 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000002405 diagnostic procedure Methods 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- OAZUOCJOEUNDEK-UHFFFAOYSA-L disodium;(5-bromo-4-chloro-1h-indol-3-yl) phosphate Chemical compound [Na+].[Na+].C1=C(Br)C(Cl)=C2C(OP([O-])(=O)[O-])=CNC2=C1 OAZUOCJOEUNDEK-UHFFFAOYSA-L 0.000 description 1
- 229960003722 doxycycline Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000005014 ectopic expression Effects 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 230000007274 generation of a signal involved in cell-cell signaling Effects 0.000 description 1
- 238000010353 genetic engineering Methods 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 230000028996 humoral immune response Effects 0.000 description 1
- 238000010324 immunological assay Methods 0.000 description 1
- 238000003780 insertion Methods 0.000 description 1
- 230000037431 insertion Effects 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 230000001678 irradiating effect Effects 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 150000002739 metals Chemical class 0.000 description 1
- 230000002906 microbiologic effect Effects 0.000 description 1
- 239000011259 mixed solution Substances 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 239000002121 nanofiber Substances 0.000 description 1
- 238000004848 nephelometry Methods 0.000 description 1
- 238000012856 packing Methods 0.000 description 1
- 239000008055 phosphate buffer solution Substances 0.000 description 1
- 239000013612 plasmid Substances 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 208000009090 primary syphilis Diseases 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 238000000159 protein binding assay Methods 0.000 description 1
- 238000004445 quantitative analysis Methods 0.000 description 1
- 230000009257 reactivity Effects 0.000 description 1
- 108010054624 red fluorescent protein Proteins 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 210000003296 saliva Anatomy 0.000 description 1
- 238000005185 salting out Methods 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 239000011669 selenium Substances 0.000 description 1
- 229910052711 selenium Inorganic materials 0.000 description 1
- 238000009366 sericulture Methods 0.000 description 1
- 230000000405 serological effect Effects 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- 229910052709 silver Inorganic materials 0.000 description 1
- 239000004332 silver Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 238000010561 standard procedure Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- 108091006106 transcriptional activators Proteins 0.000 description 1
- 230000002103 transcriptional effect Effects 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 230000001131 transforming effect Effects 0.000 description 1
- 238000004879 turbidimetry Methods 0.000 description 1
- 241000701447 unidentified baculovirus Species 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 238000001262 western blot Methods 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/571—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses for venereal disease, e.g. syphilis, gonorrhoea
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/20—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Spirochaetales (O), e.g. Treponema, Leptospira
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K17/00—Carrier-bound or immobilised peptides; Preparation thereof
- C07K17/02—Peptides being immobilised on, or in, an organic carrier
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/531—Production of immunochemical test materials
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Biotechnology (AREA)
- Analytical Chemistry (AREA)
- Pathology (AREA)
- Cell Biology (AREA)
- General Physics & Mathematics (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Food Science & Technology (AREA)
- Organic Chemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Virology (AREA)
- Peptides Or Proteins (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JPJP-P-2021-095495 | 2021-06-07 | ||
JP2021095495A JP7274680B2 (ja) | 2021-06-07 | 2021-06-07 | 梅毒トレポネーマ菌の表面抗原の混合物を用いる、抗梅毒トレポネーマ体液抗体の測定 |
PCT/JP2022/014979 WO2022259719A1 (ja) | 2021-06-07 | 2022-03-28 | 梅毒トレポネーマ菌の表面抗原の混合物を用いる、抗梅毒トレポネーマ体液抗体の測定 |
Publications (1)
Publication Number | Publication Date |
---|---|
KR20240019264A true KR20240019264A (ko) | 2024-02-14 |
Family
ID=84425219
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020247000546A KR20240019264A (ko) | 2021-06-07 | 2022-03-28 | 매독 트레포네마 균의 표면 항원의 혼합물을 사용하는, 항 매독 트레포네마 체액 항체의 측정 |
Country Status (3)
Country | Link |
---|---|
JP (2) | JP7274680B2 (ja) |
KR (1) | KR20240019264A (ja) |
WO (1) | WO2022259719A1 (ja) |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH11192089A (ja) | 1997-12-29 | 1999-07-21 | Fujirebio Inc | 梅毒トレポネマ融合dna配列及び該配列を用いて梅毒トレポネマ抗原を発現する方法 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH09288110A (ja) * | 1996-04-19 | 1997-11-04 | Sekisui Chem Co Ltd | 免疫学的梅毒診断試薬 |
JP2001228151A (ja) | 2000-02-17 | 2001-08-24 | Sekisui Chem Co Ltd | 免疫クロマトグラフィー装置 |
-
2021
- 2021-06-07 JP JP2021095495A patent/JP7274680B2/ja active Active
-
2022
- 2022-03-28 KR KR1020247000546A patent/KR20240019264A/ko unknown
- 2022-03-28 WO PCT/JP2022/014979 patent/WO2022259719A1/ja active Application Filing
- 2022-12-26 JP JP2022208292A patent/JP2023030143A/ja active Pending
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH11192089A (ja) | 1997-12-29 | 1999-07-21 | Fujirebio Inc | 梅毒トレポネマ融合dna配列及び該配列を用いて梅毒トレポネマ抗原を発現する方法 |
Non-Patent Citations (5)
Title |
---|
비특허문헌 1: V.Sambri,et al.,Western Immunoblotting with Five Treponema pallidum Recombinant Antigens for Serologic Diagnosis of Syphilis Clin.Diagno.Labo.Immuno.,8(3) p.534-539(2001) |
비특허문헌 2: 분자곤충학, pp.36-45, 공립출판 |
비특허문헌 3: Dev. Growth Differ., 56, 14-25, 2011 |
비특허문헌 4: J. Biotechnol. Biomater, S9, 004, 2012 |
비특허문헌 5: Targeted Gene Expression Using the GAL4/UAS System in the Silkworm Bombyx mori Morikazu Imamura,etal. Genetics, 165, 1329-1340 (2003) |
Also Published As
Publication number | Publication date |
---|---|
WO2022259719A1 (ja) | 2022-12-15 |
JP2022187445A (ja) | 2022-12-19 |
JP2023030143A (ja) | 2023-03-07 |
JP7274680B2 (ja) | 2023-05-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US11255854B2 (en) | Signal amplification in lateral flow and related immunoassays | |
JP2007510165A (ja) | 結合アッセイ成分 | |
US11204351B2 (en) | Compositions and methods for identifying Ehrlichia species | |
KR20240019264A (ko) | 매독 트레포네마 균의 표면 항원의 혼합물을 사용하는, 항 매독 트레포네마 체액 항체의 측정 | |
WO2019039557A1 (ja) | ジカウイルスを検出する方法及びキット | |
WO2001044499A1 (en) | Modified labeled complement components for immunoassays | |
JP2004101511A (ja) | 抗梅毒トレポネーマ抗体測定試薬及び抗梅毒トレポネーマ抗体の測定方法 |